Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters
Cells · 2025
DOI: 10.3390/cells14241973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Abraham Tettey-Matey und 11 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Biofisica, Consiglio Nazionale delle Ricerche, 16149 Genova, Italy. Hauptthemen laut MEDLINE: Chloride Channels, Endosomes, Neurodevelopmental Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Telethon Foundation, Cure CLCN4, Ministero dell'Istruzione e del Merito.
Abstract (Originalsprache)
Variants in CLCN3 and CLCN4, encoding the neuronal endosomal Cl−/H+ antiporters ClC-3 and ClC-4, are linked to neurodevelopmental disorders with broad phenotypic variability. Over sixty CLCN4 variants have been functionally characterized, showing gain- or loss-of-function (GoF or LoF) effects. While ClC-3 can function as a homodimer, ClC-4 depends on heterodimerization with ClC-3 for efficient endosomal trafficking. CLCN4, located on the X chromosome, exhibits diverse pathogenic outcomes: complete LoF variants often cause non-syndromic presentations in hemizygous males and are asymptomatic in heterozygous females, whereas certain missense variants with partial or complete LoF produce severe syndromic phenotypes in both sexes. Here, we demonstrate dominant effects of three CLCN4 variants within ClC-3/ClC-4 heterodimers using two-electrode voltage-clamp recordings in Xenopus laevis oocytes and whole-cell patch-clamp recordings in mammalian cells co-expressing both proteins via a bicistronic IRES construct. Our findings provide the first evidence of dominant-negative CLCN4 effects within ClC-3/ClC-4 complexes and establish a platform for functional analysis of additional disease-associated variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto di Biofisica, Consiglio Nazionale delle Ricerche, 16149 Genova, Italy.
- DIFI Lab, Dipartimento di Fisica, Università di Genova, 16146 Genova, Italy.
ORCID-Profile: Alessandra Picollo, Maria Antonietta Coppola, Alice Giusto, Margherita Festa, Elena Angeli, Cristiana Picco, Michael Pusch
Förderung
- Telethon Foundation
- Cure CLCN4
- Ministero dell'Istruzione e del Merito
- European Union
- Italian Ministry of Foreign Affairs
- Fondazione Telethon
- Fondazione Telethon/Cariplo
- D34 Health
Zitieren
APA
Tettey-Matey, A., Picollo, A., Sbrana, F., Coppola, M. A., Rubino, E., Giusto, A., Festa, M., Angeli, E., Picco, C., Barbieri, R., Gavazzo, P., & Pusch, M. (2025). Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters. Cells. https://doi.org/10.3390/cells14241973
Vancouver
Tettey-Matey A, Picollo A, Sbrana F, Coppola MA, Rubino E, Giusto A, et al. Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters. Cells. 2025. doi:10.3390/cells14241973
BibTeX
@article{TetteyMatey2025,
author = {Tettey-Matey, Abraham and Picollo, Alessandra and Sbrana, Francesca and Coppola, Maria Antonietta and Rubino, Eugenia and Giusto, Alice and Festa, Margherita and Angeli, Elena and Picco, Cristiana and Barbieri, Raffaella and Gavazzo, Paola and Pusch, Michael},
title = {Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14241973}
}
EUVIMED